The value of lncRNA JPX in diagnosis and prognosis of mesothelioma
10.19485/j.cnki.issn2096-5087.2023.03.011
- Author:
Mingying JIN
;
Wei SHEN
;
Junfei CHEN
;
Lingfang FENG
;
Shibo YING
;
Hailing XIA
;
Junqiang CHEN
;
Yiqiu CHEN
;
Zhaoqiang JIANG
;
Jianlin LOU
- Publication Type:Journal Article
- Keywords:
long non-coding RNA;
asbestos;
mesothelioma;
diagnosis;
prognosis
- From:
Journal of Preventive Medicine
2023;35(3):235-238
- CountryChina
- Language:Chinese
-
Abstract:
Objective :To examine the diagnostic and prognostic value of long non-coding RNA (lncRNA) JPX in mesothelioma, so as to provide insights into diagnosis and prognosis of mesothelioma.
Methods: Patients with clinically definitive diagnosis of mesothelioma from 2015 to 2019 that were sampled from asbestos processing plants in Zhejiang Province from 2015 to 2019 were recruited in the mesothelioma group, while healthy residents without asbestos exposure or asbestos-related diseases in the same area served as controls. Participants' demographics, pathologic diagnosis and imaging features were collected, and the expression of blood lncRNA JPX was detected using lncRNA microarrays. The diagnostic value of lncRNA JPX for mesothelioma was evaluated using the receiver operating characteristic (ROC) curve, and the correlation between lncRNA JPX expression and prognosis was examined among mesothelioma patients using survival analysis.
Results: There were 17 subjects in the mesothelioma group, with a mean age of (65.71±8.36) years, and 34 subjects in the controls, with a mean age of (64.24±8.70) years. LncRNA microarray detected significantly high lncRNA JPX expression in mesothelioma patients, and higher blood lncRNA JPX expression was detected in the mesothelioma group than in the control group [median (interquartile range), 1.10 (1.31) vs. 0.89 (0.54); t'=-2.300, P=0.034]. The area under the ROC curve was 0.673 (95%CI: 0.507-0.839, P=0.046), and if the cutoff was 1.759, the sensitivity and specificity were 35.3% and 100.0%, respectively. Survival analysis showed no significant difference in the survival rate of mesothelioma patients between the high lncRNA JPX expression group and the low expression group (χ2=0.212, P=0.645).
Conclusions: LncRNA JPX overexpression is detected in the blood of patients with mesothelioma, and lncRNA JPX expression presents a diagnostic value for mesothelioma; however, it shows little prognostic value for mesothelioma.
- Full text:长链非编码RNA JPX诊断间皮瘤及预后的价值研究.pdf
